AzTrials
AzTrials

Rotator Cuff DisordersEPIMARGENCT07838922

Long-term Clinical and Anatomical Evaluation of Edge-to-edge Repair of Large to Very Large Rotator Cuff Tears

A study testing MRI in people with Rotator Cuff Disorders, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Rotator cuff disorders range from impingement syndrome to partial or through-and-through tears. Partial tears most commonly affect the deep layer of the tendon, whilst through-and-through tears are characterised by a complete break in the tendon. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rotator Cuff Disorders
What is being tested?
MRI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
121 participants
Where
1 siteFrance
Study dates
1 Oct 2026to 31 Oct 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients, male or female, aged 18 or over at the time of surgery
  • Patients who underwent a edge-to-edge surgical repair of the rotator cuff between 2015 and 2017 at Jean Mermoz Hospital in Lyon (including patients who had previously undergone a first rotator cuff repair)
  • Patients with a V-shaped, retracted supraspinatus tendon tear, with or without involvement of the infraspinatus tendon, rendering direct reattachment of the tendon to the bone impossible
  • Patients for whom pre-operative and operative records are available
  • Patients agreeing to long-term follow-up comprising clinical assessment and an MRI scan
  • Patients affiliated with or covered by a social security scheme
  • French-speaking patients who have signed an informed consent form

Who cannot join

  • Patients who have undergone conventional tendon-to-bone repair rather than edge-to-edge repair
  • Patients with significant subscapularis tendon lesions requiring specific repair
  • Patients with massive or irreparable concomitant rotator cuff tears unsuitable for edge-to-edge repair
  • Patient with a history of previous shoulder surgery on the affected side, other than rotator cuff surgery
  • Patient with severe glenohumeral osteoarthritis or another shoulder condition that may skew the results
  • Patient with a contraindication to MRI
Show all 9Show fewer
  • Patients under legal protection: adults under guardianship, curatorship or other legal protection; or those deprived of their liberty by a judicial or administrative decision
  • Patients admitted to hospital without consent
  • Pregnant women.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Laurent NOVE JOSSERAND, MD contact

+ 33 4 37 53 00 24

laurent.nove-josserand@wanadoo.fr

France1 site
  • Hôpital Privé Jean Mermoz

    Lyon, 69008

    Laurent NOVE JOSSERAND, MD, + 33 437530022, laurent.nove-josserand@wanadoo.fr

Other trials in France

About this study

Rotator cuff disorders range from impingement syndrome to partial or through-and-through tears. Partial tears most commonly affect the deep layer of the tendon, whilst through-and-through tears are characterised by a complete break in the tendon. Large to very large rotator cuff tears, where repairable, can be managed using equivalent transosseous repair and double-row repair. When direct anatomical tendon-to-bone repair is no longer possible, margin convergence (MC) suturing (also known as edge-to-edge suturing) is proposed.

Studies have compared clinical outcomes between MC and other conventional techniques, but these results remain inconsistent and many studies have not ensured a sufficiently long period of patient follow-up to assess long-term clinical outcomes, resulting in an insufficient level of evidence regarding these outcomes. This is why this study has been initiated.

Read the detailed description

Rotator cuff disorders range from impingement syndrome to partial or through-and-through tears, which may present with signs and symptoms of varying severity. Partial tears most commonly affect the deep layer of the tendon, whilst through-and-through tears are characterised by a complete break in the tendon. Large to very large rotator cuff tears, where repairable, can be managed using equivalent transosseous repair and double-row repair. When direct anatomical tendon-to-bone repair is no longer possible, margin convergence (MC) suturing (also known as edge-to-edge suturing) is proposed. This is therefore a specific indication that fits between standard anatomical repairs (tendon-to-bone), partial repairs that are deliberately incomplete, and tendon transfers, for which the indications are very specific.

Studies have compared clinical outcomes between MC and other conventional techniques, but these results remain inconsistent. Beyond comparisons of clinical outcomes, patient-reported outcomes have also been insufficiently studied in relation to the MC technique. Furthermore, long-term follow-up after rotator cuff repair surgery is essential to assess structural deterioration, the progression of osteoarthritis or arthropathy, and the occurrence of delayed functional decline. However, many studies have not ensured a sufficiently long period of patient follow-up to assess long-term clinical outcomes, resulting in an insufficient level of evidence regarding these outcomes. This is why this study has been initiated.

Being tested
MRI
Keywords
Rotator cuff disorder, edge-to-edge suturing, complete break in the tendon

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIOther

    Intervention is an MRI scan of the rotator cuff with a minimum follow-up period of 10 years following a edge-to-edge surgical repair.

Study groups in NCT07838922
Study groupRoleWhat they receive
Edge-to-edge suturing armExperimentalAn MRI (Magnetic Resonance Imaging) scan of the rotator cuff is performed in patients with a minimum follow-up period of 10 years following a edge-to-edge surgical repair for a rotator cuff tear involving the supraspinatus and/or infraspinatus tendons
Receives: Other: MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sugaya classification

    The Sugaya classification is a 5-point system used to evaluate rotator cuff repair :

    Type I: sufficient thickness compared to normal cuff with homogeneous low signal Type II: sufficient thickness compared to normal cuff with partial high-intensity area Type III: <50% thickness compared to normal cuff without discontinuity suggests partial-thickness delamination tear Type IV: minor discontinuity (1-2 slices) on both oblique coronal and oblique sagittal images suggests small full-thickness tear Type V: major discontinuity (>2 slices) on both oblique coronal and sagittal images suggests medium or large full-thickness tear

    Tendon healing is defined by types I, II and III.

    Measured: 10 years

Secondary outcomes (5)
  1. Modified Goutallier-Fuchs classification

    Modified Goutallier-Fuchs classification i sused to measure fat infiltration within the supraspinatus and/or infraspinatus

    Measured: 10 years

  2. Constant score

    Constant score will measure the functional impact of injuries to supraspinatus and/or infraspinatus muscles

    Measured: Baseline and 10 years

  3. SSV (Subjective Shoulder Value)

    SSV will assess patients' subjective experience

    Measured: Baseline and 10 years

  4. VAS (Visual Analog Score)

    VAS will measure patient pain

    Measured: Baseline and 10 years

  5. Likert scale

    A 4-item Likert scale will measure patient satisfaction

    Measured: 10 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion31 Oct 2029 (estimated)
  4. Study completion31 Oct 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
121 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07838922
Sponsor's protocol ID
2026-A01261-50
Acronym
EPIMARGE
Status last verified
Sep 2026
First submitted
26 Aug 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing MRI in people with Rotator Cuff Disorders, run by GCS Ramsay Santé pour l'Enseignement et la Recherche at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Laurent NOVE JOSSERAND, MD (+ 33 4 37 53 00 24, laurent.nove-josserand@wanadoo.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sugaya classification (time frame: 10 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in